ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,420Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 1111

$1.59M Total Retail Price of All Prescriptions

Rank: 12 out of 1111

605 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 605 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

37% of this provider’s 605 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

3% of this provider’s 19,458 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
HYDROCODONE-ACETAMINOPHEN 1,356 900 S3 1 1
FUROSEMIDE 985 821 2 6
LISINOPRIL 727 534 3 2
OMEPRAZOLE 686 503 4 4
POTASSIUM CHLORIDE 630 489 5 9
LOVASTATIN 513 410 6 41
SIMVASTATIN 503 451 7 5
GABAPENTIN 453 342 8 10
AMLODIPINE BESYLATE 433 389 9 7
MELOXICAM 431 312 10 18
LEVOTHYROXINE SODIUM 406 316 11 3
METOPROLOL TARTRATE 376 314 12 12
CITALOPRAM HBR 361 267 13 14
WARFARIN SODIUM 307 280 14 19
METFORMIN HCL 292 235 15 8
HYDROCHLOROTHIAZIDE 281 228 16 11
DONEPEZIL HCL 265 265 17 25
TRAZODONE HCL 260 144 18 32
GLIPIZIDE 256 245 19 57
ZOLPIDEM TARTRATE 250 212 20 16
NEXIUM 249 187 21 26
NAMENDA 240 240 22 31
DIGOXIN 239 228 23 47
TAMSULOSIN HCL 232 186 24 28
CARVEDILOL 226 169 25 21
OXYCODONE HCL 222 81 S2 26 69
METOPROLOL SUCCINATE 215 170 27 20
LISINOPRIL-HYDROCHLOROTHIAZIDE 212 171 28 23
CLOPIDOGREL 201 181 29 30
CIPROFLOXACIN HCL 193 152 30 58
ATORVASTATIN CALCIUM 187 158 31 15
POLYETHYLENE GLYCOL 3350 183 142 32 45
ADVAIR DISKUS 182 148 33 43
ISOSORBIDE MONONITRATE 181 153 34 317
AZITHROMYCIN 171 125 35 39
PANTOPRAZOLE SODIUM 170 132 36 50
ROPINIROLE HCL 164 137 37 68
TRAMADOL HCL 156 122 38 13
DOXYCYCLINE HYCLATE 149 122 39 113
FLUTICASONE PROPIONATE 146 124 40 27
PLAVIX 144 127 41 49
CELEBREX 143 87 42 81
LYRICA 139 65 43 62
FLUOXETINE HCL 133 87 44 44
SULFAMETHOXAZOLE-TRIMETHOPRIM 133 90 44 71
METHOCARBAMOL 128 73 R 46 159
PROAIR HFA 127 109 47 38
LOVAZA 127 97 47 184
ALLOPURINOL 125 86 49 36
ESCITALOPRAM OXALATE 124 92 50 78
TORSEMIDE 122 69 51 118
RISPERIDONE 120 98 52 60
PROMETHAZINE HCL 117 66 R 53 69
SERTRALINE HCL 117 81 53 24
CYMBALTA 115 89 55 40
SPIRIVA 114 78 56 53
ALBUTEROL SULFATE 113 89 57 136
ATENOLOL 112 93 58 22
PAROXETINE HCL 104 53 59 55
TRIAMCINOLONE ACETONIDE 103 80 60 128
RANITIDINE HCL 103 90 60 29
FINASTERIDE 103 82 60 115
QUETIAPINE FUMARATE 102 69 63 76
KLOR-CON M20 101 88 64 79
AMITRIPTYLINE HCL 100 66 R 65 64
CRESTOR 100 61 65 33
FENTANYL 98 51 S2 67 65
LANTUS 89 49 68 46
SINGULAIR 89 44 68 112
NITROGLYCERIN PATCH 89 88 68 245
DOXAZOSIN MESYLATE 88 75 71 87
SYNTHROID 87 74 72 63
PRAVASTATIN SODIUM 86 72 73 17
EXELON 86 86 73 121
LANSOPRAZOLE 85 60 75 192
LOSARTAN POTASSIUM 85 77 75 34
MIRTAZAPINE 84 71 77 52
AMOX TR-POTASSIUM CLAVULANATE 81 55 78 141
CARBIDOPA-LEVODOPA 81 81 78 101
ALENDRONATE SODIUM 78 78 80 35
KLOR-CON M10 78 77 80 144
OXYCONTIN 78 0 S2 80 106
PREMARIN 77 62 R 83 90
GLIPIZIDE ER 77 64 83 99
GLYBURIDE 74 62 R 85 59
BUSPIRONE HCL 73 53 86 96
TIZANIDINE HCL 72 32 87 91
AMIODARONE HCL 72 67 87 145
HYDROXYZINE HCL 72 57 R 87 159
PREDNISONE 72 66 87 48
NITROSTAT 71 56 91 200
CLONIDINE HCL 71 59 91 42
KETOCONAZOLE 71 44 91 314
LIPITOR 69 58 94 116
MONTELUKAST SODIUM 65 40 95 206
FAMOTIDINE 65 54 95 77
ISOSORBIDE MONONITRATE ER 64 58 97 73
LOSARTAN-HYDROCHLOROTHIAZIDE 63 51 98 72
IBUPROFEN 63 45 98 66
CYCLOBENZAPRINE HCL 63 38 R 98 37
SPIRONOLACTONE 63 24 98 83
ESTRADIOL 62 38 R 102 102
ABILIFY 61 31 103 123
METHYLPREDNISOLONE 60 44 104 93
BACLOFEN 58 26 105 119
VERAPAMIL ER 58 49 105 100
PRIMIDONE 55 53 107 349
JANUVIA 55 53 107 75
VOLTAREN 55 45 107 236
MEGESTROL ACETATE 54 49 R 110 103
TRILIPIX 54 54 110 197
SSD 54 31 110 311
ZETIA 53 51 113 109
SUCRALFATE 52 51 114 125
HUMULIN 70-30 52 21 114 251
METRONIDAZOLE 51 33 116 353
CEPHALEXIN 50 38 117 89
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 11, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.